Buradasınız

Dekspantenolün Böbreği İskemi-Reperfüzyon Hasarından Koruyucu Etkisi Var mıdır?

Does Dexpantenol Protect the Kidney from Ischemia-Reperfusion Injury?

Journal Name:

Publication Year:

DOI: 
10.5262/tndt.2011.1002.05

Keywords (Original Language):

Abstract (2. Language): 
ObjectI ves : Tissue injury occurs following reperfusion after creation of ischemia. Plenty of chemical agents have been shown to protect from such an injury. We planned to evaluate the protective effect of dexpanthenol (dxp) in ischemia-reperfusion injury. MaterI al and metho ds: 24 adult rats were used and divided into 3 groups. A right nephrectomy was performed through a median laparotomy incision in all groups. Additionally, in group 1 (sham group), left nephrectomy was made 6 hours later without creation of ischemia. In group 2 (Saline group), the left kidney was left ischemic for 1 hour and reperfusion was established for 6 hours. Saline was administered intraperitoneally thirty minutes before creation of ischemia and just before reperfusion. In group 3 (Dexpanthenol group), the left kidney was left ischemic for 1 hour and reperfusion was established for 6 hours. Dxp (500 mg/kg) was administered intraperitoneally thirty minutes before creation of ischemia and just before reperfusion. A left nephrectomy was performed at the end of the 6 hours of reperfusion. Nephrectomy specimens were histopathologically analysed for congestion, inflammation and necrosis. Tissue NO, glutathione reductase, catalase and MDA levels were measured. Res ults : There was no significant differences between the groups histopathologically or biochemically. ConclusIo n: Dexpanthenol is the biologically active form of pantothenic acid and has an antioxidant effect. Our study was not in correlation with the literature regarding a protective effect of dxp on various organs via its antioxidant effect.
Abstract (Original Language): 
Amaç: İskemik kalan bir dokuda tekrar reperfüzyon sağlandığında serbest oksijen radikalleri açığa çıkmakta ve iskemiden daha yaygın bir doku hasarı oluşmaktadır. Birçok kimyasal ajanın bu hasarı önlediği bilinmektedir. Çalışmamızda, dekspantenolün (Dxp) böbreği iskemi-reperfüzyon hasarından koruyup korumadığını araştırmayı amaçladık. Gereç ve Yönte mler : Çalışmada 24 erişkin sıçan kullanıldı ve 8’erli 3 grup oluşturuldu. Tüm gruplarda orta hat laparotomi ile sağ nefrektomi yapıldı. Buna ek olarak Grup 1’de (Sham grubu) sol böbrekte iskemi oluşturulmadan 6 saat sonra sol nefrektomi yapıldı. Grup 2’de (Serum fizyolojik grubu) sol böbrek 1 saat iskemik bırakıldı. 1 saatin sonunda 6 saat süre ile reperfüzyon uygulandı. İskemiden 30 dakika önce ve reperfüzyondan hemen önce periton içine serum fizyolojik uygulandı. Grup 3’te (Dekspantenol grubu) sol böbrek 1 saat iskemik bırakıldı ve 6 saat reperfüzyon uygulandı. İskemiden 30 dakika önce ve reperfüzyondan hemen önce 500 mg/kg Dxp periton içine verildi. 6 saatin sonunda sol nefrektomi yapıldı. Alınan her bir böbreğin bir kısmı histopatolojik olarak konjesyon, inflamasyon ve nekroz, bir kısmı da doku nitrik asit, Glutatyon redüktaz, katalaz ve MDA düzeyleri yönünden incelendi. Bulgular: Histopatolojik ve biyokimyasal değerlendirmede gruplar arasında anlamlı bir fark saptanmadı (p>0,05). Sonuç: Dxp, pantotenik asidin biyolojik olarak aktif formudur ve antioksidan etkiye sahiptir. Literatürde çeşitli dokularda antioksidan etkisi ile dokuları koruyucu etkisi gösterilmiş olmasına rağmen bizim çalışmamızda böbreğin iskemi-reperfüzyon hasarında Dxp’ün koruyucu etkisi olduğu gösterilememiştir.
146-149

REFERENCES

References: 

1. Baron P, Gomez-Marin O, Casas C, Heil J, Will N, Condie R,
Burke B, Najarian JS, Sutherland DE: Renal preservation after
warm ischemia using oxygen free radical scavengers to prevent
reperfusion injury. J Surg Res 1991; 51: 60-65
2. Furuichi K, Gao JL, Murphy PM: Chemokine receptor CX3CR1
regulates renal interstitial fibrosis after ischemia-reperfusion injury.
Am J Pathol 2006; 169: 372-387
3. Sadis C, Teske G, Stokman: Nicotine protects kidney from
renal ischemia/reperfusion injury through the cholinergic antiinflammatory
pathway. PLoS ONE 2007; 2: 469
4. Loftus EV Jr, Tremaine WJ, Nelson RA, Shoemaker JD, Sandborn
WJ, Phillips SF, Hasan Y: Dexpanthenol enemas in ulcerative colitis
a pilot study. Mayo Clin Proc 1997; 72: 616-620
5. Abiko Y, Tomikawa M, Shimizu M: Enzymatic conversion of
pantothenylalcohol to pantothenic acid (Kyoto). J Vitaminol 1969;
15: 59-69
6. Slyshenkov VS, Omelyanchik SN, Moiseenok AG, Trebukhina
RV, Wojtczak L: Pantothenol protects rats against some deleterious
effects of gamma radiation. Free Radic Biol Med 1998; 24: 894-899
7. Slyshenkov VS, Piwocka K, Sikora E, Wojtczak L: Pantothenic acid
protects jurkat cells against ultraviolet light-induced apoptosis. Free
Radic Biol Med 2001; 30: 1303-1310
8. Slyshenkov VS, Dymkowska D, Wojtczak L: Pantothenic acid and
pantothenol increase biosynthesis of glutathione by boosting cell
energetics. FEBS Lett 2004; 569: 169-172
9. Slyshenkov VS, Rakowska M, Moiseenok AG, Wojtczak L:
Pantothenic acid and its derivatives protect Ehrlich ascites tumor
cells against lipid peroxidation. Free Radic Biol Med 1995; 19:
767-772
10. Jessop CE, Bulleid NJ: Glutathione directly reduces an
oxidoreductase in the endoplasmic reticulum of mammalian cells.
J Biol Chem 2004; 279: 55341-55347
11. Wojtczak L, Slyshenkov VS: Protection by pantothenic acid against
apoptosis and cell damage by oxygen free radicals-the role of
glutathione. Biofactors 2003; 17: 61-73
12. Guz G, Demirogullari B, Ulusu NN, Dogu C, Demirtola A, Kavutcu
M, Omeroglu S, Stefek M, Karasu C: Stobadine protects rat kidney
against ischaemia/reperfusion injury. Clin Exp Pharmacol Physiol
2007; 34: 210-216
13. Aguilar A, Alvarez-Vijande R, Capdevila S, Alcoberro J, Alcaraz
A: Antioxidant Patterns (Superoxide Dismutase, Glutathione
Reductase, and Glutathione Peroxidase) in Kidneys From Non–
Heart-Beating-Donors. Transplantation Proceedings 2007; 39:
249-252
14. Jefayri MK, Grace PA, Mathie RT: Attenuation of reperfusion injury
by renal ischaemic preconditioning: the role of nitric oxide. BJU Int
2000; 85: 1007-1013
15. Akgur FM, Kilinc K, Aktug T: Reperfusion injury after detorsion of
unilateral testicular torsion. Urol Res 1993; 21: 395-399
16. Liu X, Chen H, Zhan B, Xing B, Zhou J, Zhu H, Chen Z: Attenuation
of reperfusion injury by renal ischemic postconditioning: The role
of NO. Biochem Biophys Res Commun 2007; 359: 628-634
17. Ozmen S, Ayhan S, Demir Y, Siemionow M, Atabay K: Impact of
gradual blood flow increase on ischaemia-reperfusion injury in the
rat cremaster microcirculation model. J Plast Reconstr Aesthet Surg
2008; 61: 939-948
18. Filho DW, Torres MA, Bordin AL, Crezcynski-Pasa TB, Boveris A:
Spermatic cord torsion, reactive oxygen and nitrogen species and
ischemia-reperfusion injury. Mol Aspects Med 2004; 25: 199-210
19. Etensel B, Ozkisacik S, Ozkara E, Serbest YA, Oztan O, Yazici
M, Gursoy H: The protective effect of dexpanthenol on testicular
atrophy at 60th day following experimental testicular torsion.
Pediatr Surg Int 2007; 23: 271-275
20. Etensel B, Ozkisacik S, Ozkara E, Karul A, Oztan O, Yazici M,
Gürsoy H: Dexpanthenol attenuates lipid peroxidation and testicular
damage at experimental ischemia and reperfusion injury. Pediatr
Surg Int 2007; 23: 177-181
21. Abasiyanik A, Dagdonderen L: Beneficial effects of melatonin
compared with allopurinol in experimental testicular torsion. J
Pediatr Surg 2004; 39: 1238-1241

Thank you for copying data from http://www.arastirmax.com